Herbs as an Active Ingredient in Sport: Availability and Information on the Internet
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design
2.2. Data Obtained from the Website Analyzed
2.3. Search Engine
3. Results
4. Discussion
Limitations and Future Perspectives
5. Practical Application
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A
Item No. | Recommendation | Page No. | |
---|---|---|---|
Title and abstract | 1 | (a) Indicate the study’s design with a commonly used term in the title or the abstract | 1 |
(b) Provide in the abstract an informative and balanced summary of what was done and what was found | 1 lines 19–27 | ||
Introduction | |||
Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 1–3 lines 32–107 |
Objectives | 3 | State specific objectives, including any prespecified hypotheses | 3 lines 108–111 |
Methods | |||
Study design | 4 | Present key elements of study design early in the paper | 3 lines 113–127 |
Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 3 lines 129–142 |
Participants | 6 | (a) Give the eligibility criteria, and the sources and methods of selection of participants | N/A |
Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | N/A |
Data sources/measurement | 8 * | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | 3–4 lines 113–121, 144–184 |
Bias | 9 | Describe any efforts to address potential sources of bias | 3 lines 119–120 |
Study size | 10 | Explain how the study size was arrived at | N/A |
Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | N/A |
Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding | N/A |
(b) Describe any methods used to examine subgroups and interactions | N/A | ||
(c) Explain how missing data were addressed | N/A | ||
(d) If applicable, describe analytical methods taking account of sampling strategy | N/A | ||
(e) Describe any sensitivity analyses | N/A | ||
Results | |||
Participants | 13 * | (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 4 lines 186–188 |
(b) Give reasons for non-participation at each stage | 4 lines 188–193 | ||
(c) Consider use of a flow diagram | N/A | ||
Descriptive data | 14 * | (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders | 5 lines 197–208 |
(b) Indicate number of participants with missing data for each variable of interest | N/A | ||
Outcome data | 15 * | Report numbers of outcome events or summary measures | Table 1 and Table 2 |
Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included | N/A |
(b) Report category boundaries when continuous variables were categorized | N/A | ||
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | N/A | ||
Other analyses | 17 | Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses | N/A |
Discussion | |||
Key results | 18 | Summarise key results with reference to study objectives | 10–11 lines 292–342 |
Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 8 lines 343–347 |
Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | N/A |
Generalisability | 21 | Discuss the generalisability (external validity) of the study results | N/A |
Other information | |||
Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | The study was not funded |
References
- Chen, C.K.; Muhamad, A.S.; Ooi, F.K. Herbs in exercise and sports. J. Physiol. Anthropol. 2012, 31, 4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sellami, M.; Slimeni, O.; Pokrywka, A.; Kuvačić, G.; Hayes, L.D.; Milic, M.; Padulo, J. Herbal medicine for sports: A review. J. Int. Soc. Sports Nutr. 2018, 15, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Knapik, J.J.; Steelman, R.A.; Hoedebecke, S.S.; Austin, K.G.; Farina, E.K.; Lieberman, H.R. Prevalence of dietary supplement use by athletes: Systematic review and meta-analysis. Sports Med. 2016, 46, 103–123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Herbold, N.H.; Visconti, B.K.; Frates, S.; Bandini, L. Traditional and nontraditional supplement use by collegiate female varsity athletes. Int. J. Sport Nutr. Exerc. Metab. 2004, 14, 586–593. [Google Scholar] [CrossRef]
- Talemi, M.N.P.E.; Ardakani, S.M.P.; Roozbeh, B. Tribulus terrestris may decrease muscle damage markers following a high-intensity resistance exercise: A pilot study. Int. J. Vitam. Nutr. Res. 2021, 91, 500–506. [Google Scholar] [CrossRef]
- Williams, M.H.; Branch, J.D. Herbals as ergogenic aids. In Performance-Enhancing Substances in Sport and Exercise; Bahrke, M., Yesalis, C., Eds.; Human Kinetics: Champaign, IL, USA, 2002. [Google Scholar]
- Williams, M. Dietary supplements and sports performance: Herbals. J. Int. Soc. Sports Nutr. 2006, 3, 1. [Google Scholar] [CrossRef] [Green Version]
- Garthe, I.; Maughan, R.J. Athletes and supplements: Prevalence and perspectives. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 126–138. [Google Scholar] [CrossRef] [Green Version]
- Garthe, I.; Rambsbotton, R. Elite athletes, a rationale for the use of dietary supplements: A practical approach. Pharma Nutr. 2020, 14, 100234. [Google Scholar] [CrossRef]
- Council for Responsible Nutrition. 2020 CRN Consumer Survey on Dietary Supplements: Consumer Intelligence to Enhance Business Outcomes. Washington, DC (USA). 2021. Available online: https://www.crnusa.org/2020survey (accessed on 29 June 2022).
- Bach, H.V.; Kim, J.; Myung, S.K.; Cho, Y.A. Efficacy of ginseng supplements on fatigue and physical performance: A meta-analysis. J. Korean Med. Sci. 2016, 31, 1879–1886. [Google Scholar] [CrossRef]
- Choi, J.; Kim, T.-H.; Choi, T.-Y.; Lee, M.S. Ginseng for health care: A systematic review of randomized controlled trials in Korean literature. PLoS ONE 2013, 8, e59978. [Google Scholar] [CrossRef] [Green Version]
- Bener, M. Modeling and optimizing microwave-assisted extraction of antioxidants from Thymbra spicata, L. and characterization of their phenolic constituents. Food Sci. Biotechnol. 2019, 28, 1733–1745. [Google Scholar] [CrossRef]
- Kocaadam, B.; Şanlier, N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit. Rev. Food Sci. Nutr. 2017, 57, 2889–2895. [Google Scholar] [CrossRef]
- Abd El-Hack, M.E.; El-Saadony, M.T.; Swelum, A.A.; Arif, M.; Abo Ghanima, M.M.; Shukry, M.; Noreldin, A.; Taha, A.E.; El-Tarabily, K.A. Curcumin, the active substance of turmeric: Its effects on health and ways to improve its bioavailability. J. Sci. Food Agric. 2021, 101, 5747–5762. [Google Scholar] [CrossRef]
- Zhou, H.S.; Beevers, C.; Huang, S. The targets of curcumin. Curr. Drug Targets 2011, 12, 332–347. [Google Scholar] [CrossRef]
- Wright, J.S. Predicting the antioxidant activity of curcumin and curcuminoids. J. Mol. Struct. Theochem. 2002, 591, 207–217. [Google Scholar] [CrossRef]
- Wang, T.Y.; Chen, J.X. Effects of curcumin on vessel formation insight into the pro-and antiangiogenesis of curcumin. Evid.-Based Complement. Altern. Med. 2019, 2019, 1390795. [Google Scholar] [CrossRef] [Green Version]
- Reda, F.M.; El-Saadony, M.T.; Elnesr, S.S.; Alagawany, M.; Tufarelli, V. Effect of dietary supplementation of biological curcumin nanoparticles on growth and carcass traits, antioxidant status, immunity and caecal microbiota of Japanese quails. Animals 2020, 10, 754. [Google Scholar] [CrossRef]
- Martins, C.V.B.; da Silva, D.L.; Neres, A.T.M.; Magalhães, T.F.F.; Watanabe, G.A.; Modolo, L.V.; Sabino, A.A.; de Fátima, A.; de Resende, M.A. Curcumin as a promising antifungal of clinical interest. J. Antimicrob. Chemother. 2009, 63, 337–339. [Google Scholar] [CrossRef]
- Wilson, B.; Abraham, G.; Manju, V.S.; Mathew, M.; Vimala, B.; Sundaresan, S.; Nambisan, B. Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. J. Ethnopharmacol. 2005, 99, 147–151. [Google Scholar] [CrossRef]
- Reanmongkol, W.; Subhadhirasakul, S.; Khaisombat, N.; Fuengnawakit, P.; Jantasila, S.; Khamjun, A. Investigation the antinociceptive, antipyretic and anti-inflammatory activities of Curcuma aeruginosa Roxb. extracts in experimental animals. Songklanakarin J. Sci. Technol. 2006, 28, 999–1008. Available online: http://rdo.psu.ac.th/sjst/journal/28-5/10-Curcuma_aeruginosa.pdf (accessed on 6 May 2022).
- Sharifi-Rad, J.; Rayess, Y.E.; Rizk, A.A.; Sadaka, C.; Zgheib, R.; Zam, W.; Sestito, S.; Rapposelli, S.; Neffe-Skocińska, K.; Zielińska, D.; et al. Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front. Pharmacol. 2020, 11, 01021. [Google Scholar] [CrossRef]
- Di Meo, F.; Margarucci, S.; Galderisi, U.; Crispi, S.; Peluso, G. Curcumin, gut microbiota, and neuroprotection. Nutrients 2019, 11, 2426. [Google Scholar] [CrossRef] [Green Version]
- Mechoulam, R.; Parker, L.A.; Gallily, R. Cannabidiol: An overview of some pharmacological aspects. J. Clin. Pharmacol. 2002, 42, 11S–19S. [Google Scholar] [CrossRef]
- Ligresti, A.; de Petrocellis, L.; di Marzo, V. From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology. Physiol. Rev. 2016, 96, 1593–1659. [Google Scholar] [CrossRef] [Green Version]
- Kozlowski, K.F.; Ferrentino-DePriest, A.; Cerny, F. Effects of energy gel ingestion on blood glucose, lactate, and performance measures during prolonged cycling. J. Strength Cond. Res. 2021, 35, 3111–3119. [Google Scholar] [CrossRef]
- Ligresti, A.; Moriello, A.S.; Starowicz, K.; Matias, I.; Pisanti, S.; de Petrocellis, L.; Laezza, C.; Portella, G.; Bifulco, M.; di Marzo, V. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J. Pharmacol. Exp. Ther. 2006, 318, 1375–1387. [Google Scholar] [CrossRef] [Green Version]
- Wilkinson, J.D.; Williamson, E.M. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J. Dermatol. Sci. 2007, 45, 87–92. [Google Scholar] [CrossRef]
- Ramírez, B.G.; Blázquez, C.; Gómez del Pulgar, T.; Guzmán, M.; de Ceballos, M.L. Prevention of Alzheimer’s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. J. Neurosci. 2005, 25, 1904–1913. [Google Scholar] [CrossRef] [Green Version]
- Consroe, P.; Laguna, J.; Allender, J.; Snider, S.; Stern, L.; Sandyk, R.; Kennedy, K.; Schram, K. Controlled clinical trial of cannabidiol in Huntington’s disease. Pharmacol. Biochem. Behav. 1991, 40, 701–708. [Google Scholar] [CrossRef]
- De Petrocellis, L.; Ligresti, A.; Moriello, A.S.; Allarà, M.; Bisogno, T.; Petrosino, S.; Stott, C.G.; di Marzo, V. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol. 2011, 163, 1479–1494. [Google Scholar] [CrossRef] [Green Version]
- Di Marzo, V.; Piscitelli, F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics 2015, 12, 692–698. [Google Scholar] [CrossRef] [PubMed]
- Cerino, P.; Buonerba, C.; Cannazza, G.; D’Auria, J.; Ottoni, E.; Fulgione, A.; di Stasio, A.; Pierri, B.; Gallo, A. A review of hemp as food and nutritional supplement. Cannabis Cannabinoid Res. 2021, 6, 19–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Isenmann, E.; Veit, S.; Starke, L.; Flenker, U.; Diel, P. Effects of cannabidiol supplementation on skeletal muscle regeneration after intensive resistance training. Nutrients 2021, 13, 3028. [Google Scholar] [CrossRef] [PubMed]
- Houtz, A.R.; Magee, M.K.; Inaba, R.; Andreacci, J.L.; Beyer, K.S. Effects of a single dose multi-ingredient pre-workout supplement on aerobic performance in men and women. Med. Sci. Sports Exerc. 2020, 52, 766. [Google Scholar] [CrossRef]
- McCartney, D.; Benson, M.J.; Desbrow, B.; Irwin, C.; Suraev, A.; McGregor, I.S. Cannabidiol and sports performance: A narrative review of relevant evidence and recommendations for future research. Sports Med.-Open 2020, 6, 27. [Google Scholar] [CrossRef]
- Corroon, J.; Phillips, J.A. A cross-sectional study of cannabidiol users. Cannabis Cannabinoid Res. 2018, 3, 152–161. [Google Scholar] [CrossRef] [Green Version]
- Grgic, J.; Pedisic, Z.; Saunders, B.; Artioli, G.G.; Schoenfeld, B.J.; McKenna, M.J.; Bishop, D.J.; Kreider, R.B.; Stout, J.R.; Kalman, D.S.; et al. International society of sports nutrition position stand: Sodium bicarbonate and exercise performance. J. Int. Soc. Sports Nutr. 2021, 18, 61. [Google Scholar] [CrossRef]
- McLellan, T.M.; Pasiakos, S.M.; Lieberman, H.R. Effects of protein in combination with carbohydrate supplements on acute or repeat endurance exercise performance: A systematic review. Sports Med. 2014, 44, 535–550. [Google Scholar] [CrossRef]
- McLellan, T.M.; Caldwell, J.A.; Lieberman, H.R. A review of caffeine’s effects on cognitive, physical and occupational performance. Neurosci. Biobehav. Rev. 2016, 71, 294–312. [Google Scholar] [CrossRef] [Green Version]
- Pickering, C.; Grgic, J. Caffeine and exercise: What next? Sports Med. 2019, 49, 1007–1030. [Google Scholar] [CrossRef] [Green Version]
- Huestis, M.A.; Solimini, R.; Pichini, S.; Pacifici, R.; Carlier, J.; Busardò, F.P. Cannabidiol adverse effects and toxicity. Curr. Neuropharmacol. 2019, 17, 974–989. [Google Scholar] [CrossRef]
- Garberg, H.T.; Huun, M.U.; Escobar, J.; Martinez-Orgado, J.; Løberg, E.-M.; Solberg, R.; Didrik Saugstad, O. Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets. Pediatr. Res. 2016, 80, 710–718. [Google Scholar] [CrossRef]
- Rosenkrantz, H.; Fleischman, R.W.; Grant, R.J. Toxicity of short-term administration of cannabinoids to rhesus monkeys. Toxicol. Appl. Pharmacol. 1981, 58, 118–131. [Google Scholar] [CrossRef]
- Hundal, H.; Lister, R.; Evans, N.; Antley, A.; Englund, A.; Murray, R.M.; Freeman, D.; Morrison, P.D. The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group. J. Psychopharmacol. 2018, 32, 276–282. [Google Scholar] [CrossRef]
- Thiele, E.A.; Marsh, E.D.; French, J.A.; Mazurkiewicz-Beldzinska, M.; Benbadis, S.R.; Joshi, C.; Lyons, P.D.; Taylor, A.; Roberts, C.; Sommerville, K.; et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018, 391, 1085–1096. [Google Scholar] [CrossRef]
- Ran, X.; Dou, D.; Chen, H.; Ren, G. The correlations of adverse effect and tonifying effect of ginseng medicines. J. Ethnopharmacol. 2022, 291, 115113. [Google Scholar] [CrossRef]
- Izzo, A.A.; Ernst, E. Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs 2001, 61, 2163–2175. [Google Scholar] [CrossRef]
- Funk, J.L.; Frye, J.B.; Oyarzo, J.N.; Zhang, H.; Timmermann, B.N. Anti-arthritic effects and toxicity of the essential oils of turmeric (Curcuma longa L.). J. Agric. Food Chem. 2010, 58, 842–849. [Google Scholar] [CrossRef] [Green Version]
- Deshpande, S.S.; Lalitha, V.S.; Ingle, A.D.; Raste, A.S.; Gadre, S.G.; Maru, G.B. Subchronic oral toxicity of turmeric and ethanolic turmeric extract in female mice and rats. Toxicol. Lett. 1998, 95, 183–193. [Google Scholar] [CrossRef]
- Lopresti, A.L.; Maes, M.; Maker, G.L.; Hood, S.D.; Drummond, P.D. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. J. Affect. Disord. 2014, 167, 368–375. [Google Scholar] [CrossRef] [Green Version]
- Childs, E.; Hohoff, C.; Deckert, J.; Xu, K.; Badner, J.; de Wit, H. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2008, 33, 2791–2800. [Google Scholar] [CrossRef] [Green Version]
- Mielgo-Ayuso, J.; Calleja-Gonzalez, J.; del Coso, J.; Urdampilleta, A.; León-Guereño, P.; Fernández-Lázaro, D. Caffeine supplementation and physical performance, muscle damage and perception of fatigue in soccer players: A systematic review. Nutrients 2019, 11, 440. [Google Scholar] [CrossRef] [Green Version]
- O’Connor, A.M.; Sargeant, J.M.; Dohoo, I.R.; Erb, H.N.; Cevallos, M.; Egger, M.; Ersbøll, A.K.; Martin, S.W.; Nielsen, L.R.; Pearl, D.L.; et al. Explanation and elaboration document for the STROBE-vet statement: Strengthening the reporting of observational studies in epidemiology—Veterinary extension. Zoonoses Public Health 2016, 63, 662–698. [Google Scholar] [CrossRef] [Green Version]
- García, J.F.; Carriegos, M.V. Mirkwood: An online parallel crawler. In International Joint Conference: 12th International Conference on Computational Intelligence in Security for Information Systems (CISIS 2019) and 10th International Conference on EUropean Transnational Education (ICEUTE 2019), Proceedingds of the International Joint Conference: 12th CISIS ICEUTE 2019, Seville, Spain, 13–15 May 2019; Martínez Álvarez, F., Troncoso Lora, A., Sáez Muñoz, J., Quintián, H., Corchado, E., Eds.; Springer: Cham, Switzerland, 2019; pp. 47–56. Available online: https://link.springer.com/chapter/10.1007/978-3-030-20005-3_5 (accessed on 6 May 2022).
- Garcia, J.F.; Diez, M.J.; Sahagun, A.M.; Diez, R.; Sierra, M.; Garcia, J.J.; López, C.; Fernandez, M.N. Availability of antibiotics for veterinary use on the internet: A cross-sectional study. Front. Vet. Sci. 2021, 8, 798850. [Google Scholar] [CrossRef]
- Garcia, J.F.; Diez, M.J.; Sahagun, A.M.; Diez, R.; Sierra, M.; Garcia, J.J.; Fernandez, M.N. The online sale of antibiotics for veterinary use. Animals 2020, 10, 503. [Google Scholar] [CrossRef] [Green Version]
- China Internet Network Information Center (CNNIC). The 48th Statistical Report of the Development of China Internet Network. 2021. Available online: https://www.cnnic.com.cn/IDR/ReportDownloads/202111/P020211119394556095096.pdf (accessed on 7 April 2022).
- Wang, D.; Mark, G. Internet censorship in China: Examining user awareness and attitudes. ACM Trans. Comput. Interact. 2015, 22, 31. [Google Scholar] [CrossRef]
- Thomas, D.T.; Erdman, K.A.; Burke, L.M. American College of Sports Medicine. Joint position statement. Nutrition and athletic performance. Med. Sci. Sports Exerc. 2016, 48, 543–568. [Google Scholar] [CrossRef]
- Baltazar-Martins, G.; Brito de Souza, D.; Aguilar-Navarro, M.; Muñoz-Guerra, J.; Plata, M.D.M.; del Coso, J. Prevalence and patterns of dietary supplement use in elite Spanish athletes. J. Int. Soc. Sports Nutr. 2019, 16, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cuesta, A.; Segrera, A. La Importancia de la Información en el Mercado de Suplementos Nutricionales Deportivos en Bogotá. Colegio de Estudios Superiores de Administración—CESA—Administración de Empresas. Bogotá (Colombia). 2018. Available online: https://repository.cesa.edu.co/bitstream/handle/10726/2098/ADM2018-00889.pdf?sequence=5&isAllowed=y (accessed on 2 May 2022).
- Parnell, J.A.; Wiens, K.; Erdman, K.A. Evaluation of congruence among dietary supplement use and motivation for supplementation in young, Canadian athletes. J. Int. Soc. Sports Nutr. 2015, 12, 49. [Google Scholar] [CrossRef] [Green Version]
- Wardenaar, F.C.; Ceelen, I.J.M.; van Dijk, J.-W.; Hangelbroek, R.W.J.; van Roy, L.; van der Pouw, B.; de Vries, J.H.; Mensink, M.; Witkamp, R.F. Nutritional supplement use by Dutch elite and sub-elite athletes: Does receiving dietary counseling make a difference? Int. J. Sport Nutr. Exerc. Metab. 2017, 27, 32–42. [Google Scholar] [CrossRef]
- Van Thuyne, W.; van Eenoo, P.; Delbeke, F.T. Nutritional supplements: Prevalence of use and contamination with doping agents. Nutr. Res. Rev. 2006, 19, 147–158. [Google Scholar] [CrossRef] [PubMed]
- China Internet Network Information Center (CNNIC). The 49th Statistical Report of the Development of China Internet Network. 2022. Available online: http://www.cnnic.com.cn/IDR/ReportDownloads/202204/P020220424336135612575.pdf (accessed on 13 May 2022).
- Burr, J.F.; Cheung, C.P.; Kasper, A.M.; Gillham, S.H.; Close, G.L. Cannabis and athletic performance. Sports Med. 2021, 51, 75–87. [Google Scholar] [CrossRef] [PubMed]
- Kasper, A.M.; Andy Sparks, S.; Hooks, M.; Skeer, M.; Webb, B.; Nia, H.; Morton, J.P.; Close, G.L. High prevalence ofcannabidiol use within male professional rugby union and league players: A quest for pain relief and enhanced recovery. Int. J. Sport Nutr. Exerc. Metab. 2020, 30, 315–322. [Google Scholar] [CrossRef] [PubMed]
- Martin, J.H.; Hill, C.; Walsh, A.; Efron, D.; Taylor, K.; Kennedy, M.; Galettis, R.; Lightfoot, P.; Hanson, J.; Irving, H.; et al. Clinical trials with cannabis medicines—Guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: Considerations from the Australian experience. Trials 2020, 21, 932. [Google Scholar] [CrossRef] [PubMed]
- Guest, N.S.; VanDusseldorp, T.A.; Nelson, M.T.; Grgic, J.; Schoenfeld, B.J.; Jenkins, N.D.M.; Arent, S.M.; Antonio, J.; Stout, J.R.; Trexler, E.T.; et al. International society of sports nutrition position stand: Caffeine and exercise performance. J. Int. Soc. Sports Nutr. 2021, 18, 1. [Google Scholar] [CrossRef]
- Beelen, M.; Burke, L.M.; Gibala, M.J.; van Loon, L.J.C. Nutritional strategies to promote postexercise recovery. Int. J. Sport Nutr. Exerc. Metab. 2010, 20, 515–532. [Google Scholar] [CrossRef] [Green Version]
- Wickham, K.A.; Spriet, L.L. Administration of caffeine in alternate forms. Sports Med. 2018, 48, 79–91. [Google Scholar] [CrossRef] [Green Version]
- Doepker, C.; Lieberman, H.R.; Smith, A.P.; Peck, J.D.; El-Sohemy, A.; Welsh, B.T. Caffeine: Friend or foe? Annu. Rev. Food Sci. Technol. 2016, 7, 117–137. [Google Scholar] [CrossRef]
- Shergis, J.L.; Zhang, A.L.; Zhou, W.; Xue, C.C. Panax ginseng in randomised controlled trials: A systematic review. Phytother. Res. 2013, 27, 949–965. [Google Scholar] [CrossRef]
- Gillis, C.N. Panax ginseng pharmacology: A nitric oxide link? Biochem. Pharmacol. 1997, 54, 1–8. [Google Scholar] [CrossRef]
- Banister, E.W.; Calvert, T.W.; Savage, M.V.; Bach, T. A system model of physical training and athletic performance. Aust. J. Sports Med. 1975, 7, 57–61. [Google Scholar] [CrossRef]
- Bengmark, S.; Mesa, D.; Gil, A. Plant-derived health-the effects of turmeric and curcuminoids. Nutr. Hosp. 2009, 24, 273–281. Available online: https://scielo.isciii.es/pdf/nh/v24n3/revision2.pdf (accessed on 2 May 2022).
- Suhett, L.G.; de Miranda Monteiro Santos, R.; Silveira, B.; Leal, A.; de Brito, A.; de Novaes, J.F.; Lucia, C. Effects of curcumin supplementation on sport and physical exercise: A systematic review. Crit. Rev. Food Sci. Nutr. 2021, 61, 946–958. [Google Scholar] [CrossRef]
- Dias, K.A.; da Conceição, A.R.; Oliveira, L.A.; Pereira, S.M.S.; da Silva Paes, S.; Monte, L.F.; Sarandy, M.M.; Novaes, R.D.; Gonçalves, R.V.; della Lucia, C.M. Effects of curcumin supplementation on inflammatory markers, muscle damage, and sports performance during acute physical exercise in sedentary individuals. Oxid. Med. Cell. Longev. 2021, 2021, 9264639. [Google Scholar] [CrossRef]
- Goston, J.L.; Correia, M.I. Intake of nutritional supplements among people exercising in gyms and influencing factors. Nutrition 2010, 26, 604–611. [Google Scholar] [CrossRef]
- Attlee, A.; Haider, A.; Hassan, A.; Alzamil, N.; Hashim, M.; Obaid, R.S. Dietary supplement intake and associated factors among gym users in a university community. J. Diet. Suppl. 2018, 15, 88–97. [Google Scholar] [CrossRef]
Search in Spanish | Search in English | Total | |
---|---|---|---|
Number of websites reviewed | 237 | 173 | 410 |
Number of websites discarded | 27 | 38 | 65 |
Number of websites included in the study | 210 | 135 | 345 |
Number of websites selling the 4 products | 14 | 26 | 40 |
Number of websites selling cannabidiol | 19 | 35 | 54 |
Number of websites selling ginseng | 155 | 106 | 261 |
Number of websites selling caffeine | 152 | 99 | 251 |
Number of websites selling curcumin | 149 | 114 | 263 |
Number of websites per type: | |||
(They have a sports or sports nutrition section) | 45 | 19 | 64 |
| 31 | 20 | 51 |
| 28 | 26 | 54 |
| 37 | 11 | 48 |
| 20 | 19 | 39 |
| 12 | 17 | 29 |
| 28 | 7 | 35 |
| 9 | 16 | 25 |
Number of websites reporting on manufacturing laboratory | 58 | 59 | 117 |
Number of websites with information on country of production | 18 | 25 | 43 |
Number of websites reporting on ergogenic aids, nutritional supplements for sports | 66 | 18 | 84 |
Number of websites reporting on the protocol administration | 115 | 83 | 198 |
Number of websites reporting adverse reactions | 23 | 8 | 31 |
Cannabidiol | Ginseng | Caffeine | Curcumin | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spanish | English | Total | Spanish | English | Total | Spanish | English | Total | Spanish | English | Total | |
Number of websites per type: | ||||||||||||
| 5 | 7 | 12 | 18 | 15 | 33 | 22 | 18 | 40 | 39 | 15 | 54 |
| 1 | 2 | 3 | 26 | 14 | 40 | 30 | 16 | 46 | 27 | 13 | 40 |
| 0 | 4 | 4 | 22 | 20 | 42 | 26 | 20 | 46 | 24 | 25 | 49 |
| 3 | 11 | 14 | 31 | 10 | 41 | 28 | 8 | 36 | 32 | 9 | 41 |
| 4 | 1 | 5 | 18 | 16 | 34 | 17 | 16 | 33 | 7 | 18 | 25 |
| 0 | 1 | 1 | 8 | 13 | 21 | 6 | 10 | 16 | 4 | 15 | 19 |
| 3 | 4 | 7 | 24 | 4 | 28 | 16 | 5 | 21 | 11 | 5 | 16 |
| 3 | 5 | 8 | 8 | 14 | 22 | 7 | 6 | 13 | 5 | 14 | 19 |
Number of units sold | 95 | 739 | 834 | 4896 | 3694 | 8590 | 5699 | 3226 | 8925 | 2769 | 2866 | 5635 |
Pharmaceutical forms | ||||||||||||
| 30 | 249 | 279 | 2455 | 1677 | 4132 | 2006 | 1045 | 3051 | 1728 | 1977 | 3705 |
| 17 | 3 | 20 | 843 | 336 | 1179 | 686 | 237 | 923 | 447 | 250 | 697 |
| 0 | 1 | 1 | 261 | 279 | 540 | 206 | 172 | 378 | 94 | 144 | 238 |
| 0 | 0 | 0 | 274 | 124 | 398 | 34 | 6 | 40 | 26 | 0 | 26 |
| 0 | 0 | 0 | 207 | 134 | 341 | 64 | 1 | 65 | 19 | 17 | 36 |
| 0 | 0 | 0 | 48 | 11 | 59 | 115 | 58 | 173 | 46 | 9 | 55 |
| 0 | 10 | 10 | 164 | 278 | 442 | 50 | 18 | 68 | 156 | 14 | 170 |
| 0 | 1 | 1 | 66 | 3 | 69 | 200 | 104 | 304 | 13 | 17 | 30 |
| 14 | 6 | 20 | 79 | 163 | 242 | 150 | 177 | 327 | 0 | 10 | 10 |
| 0 | 1 | 1 | 46 | 75 | 121 | 612 | 286 | 898 | 1 | 61 | 62 |
| 0 | 66 | 66 | 13 | 23 | 36 | 112 | 67 | 179 | 20 | 81 | 101 |
| 0 | 8 | 8 | 211 | 234 | 445 | 1309 | 1002 | 2311 | 183 | 237 | 420 |
| 0 | 0 | 0 | 38 | 123 | 161 | 0 | 1 | 1 | 0 | 0 | 0 |
| 4 | 36 | 40 | 16 | 25 | 41 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | 316 | 319 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 6 |
| 0 | 11 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 4 |
| 0 | 0 | 0 | 47 | 55 | 102 | 25 | 15 | 40 | 0 | 4 | 4 |
| 0 | 0 | 0 | 16 | 18 | 34 | 21 | 13 | 34 | 0 | 0 | 0 |
| 0 | 0 | 0 | 9 | 16 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
| 25 | 25 | 50 | 40 | 32 | 72 | 18 | 12 | 30 | 8 | 18 | 26 |
| 2 | 4 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 0 | 2 | 2 | 63 | 88 | 151 | 91 | 12 | 103 | 23 | 21 | 44 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Garcia, J.F.; Arribalzaga, S.; Díez, R.; Lopez, C.; Fernandez, M.N.; Garcia, J.J.; Diez, M.J.; Seco-Calvo, J.; Sierra, M.; Sahagún, A.M. Herbs as an Active Ingredient in Sport: Availability and Information on the Internet. Nutrients 2022, 14, 2764. https://doi.org/10.3390/nu14132764
Garcia JF, Arribalzaga S, Díez R, Lopez C, Fernandez MN, Garcia JJ, Diez MJ, Seco-Calvo J, Sierra M, Sahagún AM. Herbs as an Active Ingredient in Sport: Availability and Information on the Internet. Nutrients. 2022; 14(13):2764. https://doi.org/10.3390/nu14132764
Chicago/Turabian StyleGarcia, Juan F., Soledad Arribalzaga, Raquel Díez, Cristina Lopez, M. Nelida Fernandez, Juan J. Garcia, M. Jose Diez, Jesús Seco-Calvo, Matilde Sierra, and Ana M. Sahagún. 2022. "Herbs as an Active Ingredient in Sport: Availability and Information on the Internet" Nutrients 14, no. 13: 2764. https://doi.org/10.3390/nu14132764
APA StyleGarcia, J. F., Arribalzaga, S., Díez, R., Lopez, C., Fernandez, M. N., Garcia, J. J., Diez, M. J., Seco-Calvo, J., Sierra, M., & Sahagún, A. M. (2022). Herbs as an Active Ingredient in Sport: Availability and Information on the Internet. Nutrients, 14(13), 2764. https://doi.org/10.3390/nu14132764